| |
| Enterostatin (Ala-Pro-Gly-Pro-Arg), human, mouse, rat |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP13462-0.5 mg
| 0.5 mg | $ 57.00 | MSDS: 20080909214401 (PDF)
References:
- Arsenijevic D, Gallmann et al. Enterostatin decreases postprandial pancreatic UCP2 mRNA levels and increases plasma insulin and amylin. Am J Physiol Endocrinol Metab. Jul 2005, 289(1):E40-5.
- Lin L, Park M et al. Different metabolic responses to central and peripheral injection of enterostatin.
Am J Physiol Regul Integr Comp Physiol. Apr 2006, 290(4):R909-15.
- Inui A, Asakawa A et al. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. Mar 2004, 18(3):439-56.
|
|---|
| Full Name | | Enterostatin (Ala-Pro-Gly-Pro-Arg), human, mouse, rat |
|
Sequence
(one-letter code) |
APGPR | Sequence
(three-letter code) | {ALA}{PRO}{GLY}{PRO}{ARG} |
|---|
| Description | Enterostatin, a pentapeptide released from the exocrine pancreas and gastrointestinal tract, selectively inhibits fat intake through activation of an afferent vagal signaling pathway. |
|---|
| Solubility | The peptide is soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weigh out a smaller portion of the contents. |
|---|
| Formula | C21H36N8O6 |
|---|
| M.W. | 496.56 |
|---|
| Purity | >95% |
|---|
| Storage | Before use, store the peptide in the DRY form at 0°C-5°C. For best and most repeatable results, rehydrate the peptide immediately before use. Do not re-freeze any unused portions. |
| * For Non-Clinical Research Use Only * If you cannot find your peptides on our list, try our Express PeptideTM Service, and receive high-quality peptides in eight business days, guaranteed. Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance. |
|
